Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x107px
Organisation › Details

Padlock Therapeutics Inc.

Padlock Therapeutics is a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases. The company leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. Padlock was founded by scientists at The Scripps Research Institute in conjunction with Atlas Venture. Padlock's Series A investors include Atlas Ventures, Johnson & Johnson Innovation - JJDC, MS Ventures, and Index Ventures. *

 

Period Start 2014-01-01 existent
  Group Bristol-Myers Squibb (BMS) (Group)
Products Industry protein-arginine deiminase enzyme inhibitor (PAD inhibitor)
  Industry 2 drug development
Persons Person Gilman, Michael (Arrakis Therapeutics 201702– CEO before Padlock Therapeutics 201501 CEO)
  Person 2 Truex, Samantha (Padlock Therapeutics 201603 CBO)
     
Region Region Cambridge, MA
  Country United States (USA)
  Street 25 First Street
  City 02141 Cambridge, MA
  Tel +1-978-381-9601
    Address record changed: 2015-02-08
     
Basic data Employees n. a.
     
    * Document for �About Section�: Evotec AG. (1/7/15). "Press Release: Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-term Collaboration". Hamburg.
     
   
Record changed: 2017-04-01

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px

More documents for Bristol-Myers Squibb (BMS) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioPharm America 2018 Boston Partnering 600x60px




» top